In the US, the government is increasingly prioritizing biosecurity and biodefense. Last quarter, we announced a new contract with the CDC to expand our traveler-based COVID-19 genomic surveillance program at certain US airports.

Nov 14, 2022 / receipt, needs a key / Jason Kelly, CEO | earnings call 2022-11-14 | transcript 8c4241d1-cf1c-4a6e-9c19-cc8a22614c29 | chars 36954-37182 | segment 37

While our K-12 testing business has been quieter over the summer, just because many schools are closed, as expected, we're very excited to be seeing traction across longer-term biosecurity opportunities, including being awarded a contract from the CDC to expand our traveler-based COVID-19 monitoring services, with an overall potential to exceed $61 million to Ginkgo and its partners based on CDC program options and public health priorities.

Aug 15, 2022 / receipt, needs a key / Jason Kelly, CEO | earnings call 2022-08-15 | transcript cd3afc1c-982a-4f10-9827-ea3fabebb282 | chars 5018-5462 | segment 5

Associate Director, Environmental Health and Safety | {"ats": "greenhouse", "city": "Boston", "state": "MA", "job_id": "5238882007", "remote": false, "category": "other", "function": "retail", "locati

company_statement / Sep 15, 2026 / receipt

our ability to realize near-term and long-term cost savings associated with our site consolidation plans, including the ability to terminate leases or find sub-lease tenants for unused facilities

ir_statement / Sep 15, 2026 / receipt

Demonstrate the capabilities of Autonomous Labs by decommissioning the majority of Ginkgo's lab benches, walk-up automation, and workcells and moving our three R&D services businesses onto a single, l

ir_statement / Sep 15, 2026 / receipt

Cash burn to $125M target

ir_statement / Sep 15, 2026 / receipt

Cash burn to $150M target

ir_statement / Sep 15, 2026 / receipt

Carrying cost of excess space (net of sublease income) (5) 14 12 15% 30 24 25%

ir_statement / Sep 15, 2026 / receipt

General and administrative (2) 12 16 (26%) 24 36 (31%)

ir_statement / Sep 15, 2026 / receipt

Restructuring charges (4) 0 4 (100%) 0 8 (100%)

ir_statement / Sep 15, 2026 / receipt

Ginkgo reaffirms total cash burn guidance

ir_statement / Sep 15, 2026 / receipt

our ability to realize near-term and long-term cost savings associated with our site consolidation plans, including the ability to terminate leases or find sub-lease tenants for unused facilities

ir_statement / Sep 15, 2026 / receipt

the potential negative impact on our business of our restructuring or the failure to realize the anticipated savings associated therewith

ir_statement / Sep 15, 2026 / receipt

Book new sales of Autonomous Labs in biopharma, national labs, and research universities.

ir_statement / Sep 15, 2026 / receipt